355 related articles for article (PubMed ID: 23532855)
1. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
2. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
4. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
[TBL] [Abstract][Full Text] [Related]
5. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.
Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221
[TBL] [Abstract][Full Text] [Related]
6. Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains.
Khandelwal S; Roche PA
J Biol Chem; 2010 Nov; 285(46):35303-10. PubMed ID: 20833718
[TBL] [Abstract][Full Text] [Related]
7. Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells.
Furuta K; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19380-5. PubMed ID: 23129633
[TBL] [Abstract][Full Text] [Related]
8. MHC class II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1 phenotype.
Buatois V; Baillet M; Bécart S; Mooney N; Leserman L; Machy P
J Immunol; 2003 Dec; 171(11):5812-9. PubMed ID: 14634090
[TBL] [Abstract][Full Text] [Related]
9. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of MHC Class II by March-I Regulates Dendritic Cell Fitness.
Kim HJ; Bandola-Simon J; Ishido S; Wong NW; Koparde VN; Cam M; Roche PA
J Immunol; 2021 Feb; 206(3):494-504. PubMed ID: 33318291
[TBL] [Abstract][Full Text] [Related]
11. Activation of Dendritic Cells Alters the Mechanism of MHC Class II Antigen Presentation to CD4 T Cells.
Cho KJ; Ishido S; Eisenlohr LC; Roche PA
J Immunol; 2020 Mar; 204(6):1621-1629. PubMed ID: 31996461
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells.
Walseng E; Furuta K; Bosch B; Weih KA; Matsuki Y; Bakke O; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20465-70. PubMed ID: 21059907
[TBL] [Abstract][Full Text] [Related]
13. Transport of peptide-MHC class II complexes in developing dendritic cells.
Turley SJ; Inaba K; Garrett WS; Ebersold M; Unternaehrer J; Steinman RM; Mellman I
Science; 2000 Apr; 288(5465):522-7. PubMed ID: 10775112
[TBL] [Abstract][Full Text] [Related]
14. Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells.
Setterblad N; Roucard C; Bocaccio C; Abastado JP; Charron D; Mooney N
J Leukoc Biol; 2003 Jul; 74(1):40-8. PubMed ID: 12832441
[TBL] [Abstract][Full Text] [Related]
15. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
Ho NI; Camps MGM; de Haas EFE; Ossendorp F
Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
[TBL] [Abstract][Full Text] [Related]
16. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation.
Cao X; Sugita M; Van Der Wel N; Lai J; Rogers RA; Peters PJ; Brenner MB
J Immunol; 2002 Nov; 169(9):4770-7. PubMed ID: 12391186
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.
van Niel G; Wubbolts R; Ten Broeke T; Buschow SI; Ossendorp FA; Melief CJ; Raposo G; van Balkom BW; Stoorvogel W
Immunity; 2006 Dec; 25(6):885-94. PubMed ID: 17174123
[TBL] [Abstract][Full Text] [Related]
18. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells.
Nijman HW; Kleijmeer MJ; Ossevoort MA; Oorschot VM; Vierboom MP; van de Keur M; Kenemans P; Kast WM; Geuze HJ; Melief CJ
J Exp Med; 1995 Jul; 182(1):163-74. PubMed ID: 7790816
[TBL] [Abstract][Full Text] [Related]
19. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
